Evidence map›Paper›PMID 24813205›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Antigen-dependent versus -independent activation of invariant NKT cells during infection.

Keli L Holzapfel, Aaron J Tyznik, Mitchell Kronenberg, Kristin A Hogquist

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Human CD4Immunology · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. NKT Cells Contribute to the Control of Microbial Infections.Frontiers in cellular and infection microbiology · 2021
    Review
  15. Review
  16. Review
  17. License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Keli L HolzapfelDepartment of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455; and.
Aaron J TyznikDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Mitchell KronenbergDivision of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Kristin A HogquistDepartment of Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455; and hogqu001@umn.edu.
La Jolla Institute for Immunology · USUniversity of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HEATHER Hammond NELSON · 1998 to 2026
$100.4M
Development and Function of NKT CellsR37AI071922 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2006 to 2015
$4.9M
TCR signal strength in thymic selectionR37AI039560 · NIAID · UNIVERSITY OF MINNESOTA · PI HOGQUIST, KRISTIN A. · 2012 to 2021
$3.7M
Indirect recognition of microbes by NKT cellsR01AI069296 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2007 to 2011
$2.1M
Stem Cell Biology Training ProgramT32HD060536 · NICHD · UNIVERSITY OF MINNESOTA · PI KAUFMAN, DAN S. · 2010 to 2014
$779k
Activation of NKT cells by cytomegalovirusR21AI076864 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A, KRONENBERG, MITCHELL · 2009 to 2010
$519k
Invariant NKT cell responses to viral infections and tumorsF32AI080087 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI TYZNIK, AARON JACOB · 2008 to 2010
$142k
NCI NIH HHS P30 CA077598NIAID NIH HHS F32 AI080087NIAID NIH HHS F32 AI80087NIAID NIH HHS R01 AI069296NIAID NIH HHS R01 AI69296NIAID NIH HHS R21 AI076864NIAID NIH HHS R37 AI039560NIAID NIH HHS R37 AI071922NIAID NIH HHS R37-AI39560NIAID NIH HHS R37 AI71922NICHD NIH HHS T32 HD060536
6 · The paper itself

Abstract

CD1d-reactive invariant NKT cells (iNKT) play a vital role in determining the characteristics of immune responses to infectious agents. Previous reports suggest that iNKT cell activation during infection can be: 1) solely driven by cytokines from innate immune cells, 2) require microbial Ag, or 3) require self-Ag. In this study, we examined the role of Ag receptor stimulation in iNKT cells during several bacterial and viral infections. To test for Ag receptor signaling, Nur77(gfp) BAC transgenic mice, which upregulate GFP in response to Ag receptor but not inflammatory signals, were analyzed. iNKT cells in the reporter mice infected with mouse CMV produced IFN-γ but did not upregulate GFP, consistent with their reported CD1d-independent activation. However, two bacteria known to produce lipid Ags for iNKT cells induced GFP expression and cytokine production. In contrast, although Salmonella typhimurium was proposed to induce the presentation of a self-lipid, iNKT cells produced IFN-γ but did not upregulate GFP postinfection in vivo. Even in CD1d-deficient hosts, iNKT cells were still able to produce IFN-γ after S. typhimurium infection. Furthermore, although it has been proposed that endogenous lipid presentation is a result of TLR stimulation of APCs, injection of different TLR agonists led to iNKT cell IFN-γ but not increased GFP expression. These data indicate that robust iNKT cell responses to bacteria, as well as viruses, can be obtained in the absence of antigenic stimulation.

Indexed as

Antigen PresentationLymphocyte ActivationAnimalsAntigens, BacterialAntigens, CD1dMiceMice, KnockoutNatural Killer T-CellsSalmonella InfectionsSalmonella typhimuriumAntigens, BacterialAntigens, CD1dCD1d antigen, mouse

Identifiers

PMID24813205
PMCPMC4053538
OpenAlexW2171071101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.